Covid19NCT04650035
The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak
An observational study of Covid19, run by Yarmouk University at 1 site in Jordan.
Trial summary
Background: COVID-19 is an acute respiratory pandemic with no available effective antiviral treatment or widely available effective vaccine. Surgical practice has faced widespread problems due to the pandemic including viral transmission risk and cross-infection, staffing problems, prioritizations of surgical… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Covid19
- How many people
- 60 participants
- Where
- 1 siteJordan
- Study dates
- 1 Nov 2020to 10 Nov 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Consultants and specialists of all general and special surgical specialties and subspecialties in Jordan
Who may be able to join
- Consultants and specialists of all general and special surgical specialties and subspecialties in Jordan
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak : A Survey
Background: COVID-19 is an acute respiratory pandemic with no available effective antiviral treatment or widely available effective vaccine. Surgical practice has faced widespread problems due to the pandemic including viral transmission risk and cross-infection, staffing problems, prioritizations of surgical procedures and lack of beds due to occupancy of hospitals and ICU beds with COVID-19 patients; Methods: A survey was conducted between October 31 to November 4, 2020, through google forms. The questionnaire involved 16 questions sent to consultants and specialists of all general and special surgical specialties and subspecialties in Jordan;
Read the detailed description
A survey was conducted between October 31 and November 4, 2020. The questionnaire was made through google forms, and a consent was taken from the Jordan medical association to send the link to surgeons in Jordan through the social media and the official WhatsApp groups. The survey was introduced with the invitation to participate of surgeons of all general and special surgical specialties and subspecialties. The aim of the survey was mentioned in the introduction which was to evaluate the impact of COVID-19 on surgical practice in Jordan during the second outbreak of COVID-19, and it was explained that the aim of the survey was for research purposes only and that it was totally anonymous with privacy preserved, and no identifying information required. Also, it was noted that we have added spaces for written views and recommendations.
The questionnaire involved 16 questions of the multiple-choice, the dropdown, the multiple check, and the short answer questions. The first 2 questions were about the specialty and the place of work whether it was the ministry of health, the royal medical services, the university hospitals, or the non-governmental organizations. The 3rd and 4th questions were about the hospital where the participant works whether it admits COVID-19 patients and/or ordinary patients. The Questions from the 5th to the 8th were about the volume of work in terms of the number of elective and emergency surgeries during the month of October 2020 in comparison to the average monthly rate during the year 2019. The questions from the 9th to the 15th were about the problems that might have been faced in managing elective and emergency cases during the month of October 2020 in relation to COVID-19. The last question was a multiple checkbox question with an added space for giving the possible recommendations to manage the situation.
- Conditions
- Covid19
- Medical subject headings
- COVID-19
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of surgical operations performed whether elective or emergency
difference between the monthly rate of operations during 2019 and the month of October 2020.
Measured: October 2020
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Dec 2020
- Study start1 Nov 2020
- Primary completion4 Nov 2020
- Study completion10 Nov 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Covid19Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yarmouk University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Raed M Ennab, Yarmouk University
- Investigators
- Raed M Ennab, Study director, Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04650035
- Sponsor's protocol ID
- The Impact of COVID-19 Jordan
- Status last verified
- Dec 2020
- First submitted
- 1 Dec 2020
- Last updated
- 3 Dec 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
PubMed 32169119Lam S, Lombardi A, Ouanounou A. COVID-19: A review of the proposed pharmacological treatments. Eur J Pharmacol. 2020 Nov 5;886:173451. doi: 10.1016/j.ejphar.2020.173451. Epub 2020 Aug 6.
PubMed 32768505Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, O'Neill N, Iosifidis C, Griffin M, Mathew G, Agha R. Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 1. Int J Surg. 2020 Jul;79:168-179. doi: 10.1016/j.ijsu.2020.05.022. Epub 2020 May 12.
PubMed 32407799Coccolini F, Perrone G, Chiarugi M, Di Marzo F, Ansaloni L, Scandroglio I, Marini P, Zago M, De Paolis P, Forfori F, Agresta F, Puzziello A, D'Ugo D, Bignami E, Bellini V, Vitali P, Petrini F, Pifferi B, Corradi F, Tarasconi A, Pattonieri V, Bonati E, Tritapepe L, Agnoletti V, Corbella D, Sartelli M, Catena F. Surgery in COVID-19 patients: operational directives. World J Emerg Surg. 2020 Apr 7;15(1):25. doi: 10.1186/s13017-020-00307-2.
PubMed 32264898Russell FM, Greenwood B. Who should be prioritised for COVID-19 vaccination? Hum Vaccin Immunother. 2021 May 4;17(5):1317-1321. doi: 10.1080/21645515.2020.1827882. Epub 2020 Nov 3.
PubMed 33141000
Study at a glance
From the registry record, last updated by the sponsor on 3 Dec 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak : A Survey
- ClinicalTrials.gov ID
- NCT04650035
- Acronym / sponsor ID
- The Impact of COVID-19 Jordan
- Conditions
- Covid19
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Yarmouk UniversityUniversity, hospital or other
- Study start
- 1 Nov 2020 (actual)
- Primary completion
- 4 Nov 2020 (actual)
- Study completion
- 10 Nov 2020 (actual)
- First posted
- 2 Dec 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: COVID-19 is an acute respiratory pandemic with no available effective antiviral treatment or widely available effective vaccine. Surgical practice has faced widespread problems due to the pandemic including viral transmission risk and cross-infection, staffing problems, prioritizations of surgical procedures and lack of beds due to occupancy of hospitals and ICU beds with COVID-19 patients; Methods: A survey was conducted between October 31 to November 4, 2020, through google forms. The questionnaire involved 16 questions sent to consultants and specialists of all general and special surgical specialties and subspecialties in Jordan;
Detailed description
A survey was conducted between October 31 and November 4, 2020. The questionnaire was made through google forms, and a consent was taken from the Jordan medical association to send the link to surgeons in Jordan through the social media and the official WhatsApp groups. The survey was introduced with the invitation to participate of surgeons of all general and special surgical specialties and subspecialties. The aim of the survey was mentioned in the introduction which was to evaluate the impact of COVID-19 on surgical practice in Jordan during the second outbreak of COVID-19, and it was explained that the aim of the survey was for research purposes only and that it was totally anonymous with privacy preserved, and no identifying information required. Also, it was noted that we have added spaces for written views and recommendations.
The questionnaire involved 16 questions of the multiple-choice, the dropdown, the multiple check, and the short answer questions. The first 2 questions were about the specialty and the place of work whether it was the ministry of health, the royal medical services, the university hospitals, or the non-governmental organizations. The 3rd and 4th questions were about the hospital where the participant works whether it admits COVID-19 patients and/or ordinary patients. The Questions from the 5th to the 8th were about the volume of work in terms of the number of elective and emergency surgeries during the month of October 2020 in comparison to the average monthly rate during the year 2019. The questions from the 9th to the 15th were about the problems that might have been faced in managing elective and emergency cases during the month of October 2020 in relation to COVID-19. The last question was a multiple checkbox question with an added space for giving the possible recommendations to manage the situation.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Consultants and specialists of all general and special surgical specialties and subspecialties in Jordan
Key inclusion criteria (1 listed)
- Consultants and specialists of all general and special surgical specialties and subspecialties in Jordan
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of surgical operations performed whether elective or emergency
Time frame: October 2020
difference between the monthly rate of operations during 2019 and the month of October 2020.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Dec 2020.
- Background: PubMed 32169119Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
- Background: PubMed 32768505Lam S, Lombardi A, Ouanounou A. COVID-19: A review of the proposed pharmacological treatments. Eur J Pharmacol. 2020 Nov 5;886:173451. doi: 10.1016/j.ejphar.2020.173451. Epub 2020 Aug 6.
- Background: PubMed 32407799Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, O'Neill N, Iosifidis C, Griffin M, Mathew G, Agha R. Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 1. Int J Surg. 2020 Jul;79:168-179. doi: 10.1016/j.ijsu.2020.05.022. Epub 2020 May 12.
- Background: PubMed 32264898Coccolini F, Perrone G, Chiarugi M, Di Marzo F, Ansaloni L, Scandroglio I, Marini P, Zago M, De Paolis P, Forfori F, Agresta F, Puzziello A, D'Ugo D, Bignami E, Bellini V, Vitali P, Petrini F, Pifferi B, Corradi F, Tarasconi A, Pattonieri V, Bonati E, Tritapepe L, Agnoletti V, Corbella D, Sartelli M, Catena F. Surgery in COVID-19 patients: operational directives. World J Emerg Surg. 2020 Apr 7;15(1):25. doi: 10.1186/s13017-020-00307-2.
- Background: PubMed 33141000Russell FM, Greenwood B. Who should be prioritised for COVID-19 vaccination? Hum Vaccin Immunother. 2021 May 4;17(5):1317-1321. doi: 10.1080/21645515.2020.1827882. Epub 2020 Nov 3.
- Department of Statistics Jordan. Population Count. (2020).Link provided by the sponsor.
- National Center for Security and Crises Management. COVID-19 in Jordan. (2020).Link provided by the sponsor.
- Prime Ministry of Jordan. Official Reports. (2020).Link provided by the sponsor.
- Jordanian Ministry of Health. COVID-19 in Jordan. (2020).Link provided by the sponsor.
- The American Board of Surgery official website, COVID-19 Guidelines and ResourcesLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Covid19
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
RecruitingObservational study
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Pneumonia, Community-Acquired, COVID-19 Pneumonia
RecruitingPhase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Raed M Ennab study director
Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Covid19, run by Yarmouk University at 1 site in Jordan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of surgical operations performed whether elective or emergency (time frame: October 2020). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04650035, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2020.